Refresher course on prostate cancer

Chairs:  G. Baciarello, IT – B. Šeruga, SI

The refresher course on prostate cancer has been designed for medical and clinical oncologists with the aim to provide an update on the -state of-the art therapeutic options as well as an overview of the latest advances in the field. Practical training will be offered in the frame of clinical case presentations, prepared and presented by participants and discussed with the faculty. 

Attendance to the course is limited and by application only. Priority will be given to applicants who have attended a previous ESO masterclass. 

LEARNING OBJECTIVES 

• Update on the latest advances in screening and diagnostic procedures 
• Update on the latest advances and on the state-of- the-art treatment options 
• Learn about the management of specific situations 
• Understand the pathology and molecular characteristics of prostate cancer 
• Learn about the future development in the treatment of prostate cancer 
• Debate controversies and challenges in prostate cancer 
• Improve practical skills in multidisciplinary management and follow-up of patients with prostate cancer 

OFFICIAL LANGUAGE 

The official language will be English. No translation will be available. 

CME ACCREDITATION 

The refresher course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 10 European CME credits (ECMEC®s).

ESCO - The ESO College 

 
Being selected to take part in this ESO activity gives participants eligibility to enrol in ESCO - the College of the European School of Oncology. 
This event also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. 
Full and active participation in the event earns participants 9 ESCO credits. 
Visit www.ESCO.org for more information on how to join ESCO. 

PARTICIPATION 

Attendance is limited to 30 participants and admittance is by competitive application only. Priority will be given to applicants who have attended an ESO masterclass. 

Applicants should meet the following profile: 

• Age between 30 and 45 years 
• At least 2-3 years’ experience in medical oncology 
• Fluency in English 

Successful applicants are granted free registration. 

Accommodation at the course venue for arrival on 24th May and departure on the 26th May will be provided to participants not residing in the Ljubljana area. 

ORGANISING SECRETARIAT 

Mariachiara Deleo
European School of Oncology (ESO)
Via Turati 29
IT- 20121 Milan

ph  +39 335 181 4541
email: mdeleo@eso.net

Dolores Knupfer 
European School of Oncology (ESO) 
Via Vicenzo Vela 6 
CH- 6500 Bellinzona 
 
ph +41 91 820 09 52 
e-mail: dknupfer@eso.net 

APPLICATIONS CLOSED

Interested candidates should apply online providing:

• Application template
• Abstract
• Letter describing motivation for attending
• Short CV (template CV) with the list of publications (if the list of publication is not provided, it will be assumed that no articles have been published)

If you are a past ESO Masterclass participant, you only need to submit the application template and abstract.

ABSTRACT

Applicants are requested to submit an abstract describing a clinical case related to prostate cancer on one of the following categories:

• Localized prostate cancer (to treat or not to treat)
• Locally-advanced prostate cancer
• Biochemical recurrence/Persistent PSA
• Advanced castrate sensitive prostate cancer
• Advanced castrate resistant prostate cancer

A selected number of admitted participants will have the opportunity to present their clinical case in the format of a clinical grand round discussion with the chairs, other faculty members and participants within plenary tumour board sessions in the programme. The application outcome will be notified by e-mail by the 12^th April.

Giulia Baciarello, San Camillo-Forlanini Hospitals, Genitourinary Oncology Dpt., Rome, IT
Tanja Cufer, University of Ljubljana, Medical Faculty, Ljubljana, SI
Berardino De Bari, Neuchâtel Hospital Network, Dept. of Radiation Oncology, La Chaux-de-Fonds, CH
Andrea Farolfi, Policlinico S.Orsola, PAD 30, Bologna, IT
Simon Hawlina, Ljubljana University Medical Centre, Department of Urology, Ljubljana, SI
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, IT
Giuseppe Petralia, European Institute of Oncology - IEO, Radiology Department, Milan, IT
Miha Pukl, Institute of Oncology, Urology Department, Ljubljana|, SI
Bostjan Seruga, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Vida Stegel, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Arnoud Templeton, St. Claraspital Basel, Oncology Dept, Basel, CH
Metka Volavšek, University of Ljubljana, Institute of Pathology, Faculty of Medicine, Ljubljana, SI